Skip to main content
. Author manuscript; available in PMC: 2018 Jun 27.
Published in final edited form as: Mol Carcinog. 2015 Sep 7;55(11):1517–1525. doi: 10.1002/mc.22405

Figure 1. Vaccine Design & Experimental Strategy.

Figure 1.

A. Schematic of the EGFR protein. Red lines indicate the peptide epitopes selected as part of our vaccine.

B. Representation of the homology between the peptides composing the vaccine and corresponding mouse sequences.

C. Schematic of the experimental design outlining timing of vaccine administration, induction of the oncogenic transgene, imaging time points and experimental endpoint.